Home › Funds › TOTH FINANCIAL ADVISORY CORP › ABT

TOTH FINANCIAL ADVISORY CORP position in ABT

ABBOTT LABORATORIES · Health Care

TOTH FINANCIAL ADVISORY CORP reported holding 88,242 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 0.87% of its reported portfolio and ranking #39 among its reported holdings. TOTH FINANCIAL ADVISORY CORP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)88.24K sh
Reported value held$8.72M
Portfolio Weight0.87%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How TOTH FINANCIAL ADVISORY CORP's ABT position evolved

TOTH FINANCIAL ADVISORY CORP first disclosed a stake in ABT in Q3 2023 at 103,951 shares (US$10.1M). The position peaked in Q3 2025 at 112,085 shares, worth US$15.0M. Across 13 filings, TOTH FINANCIAL ADVISORY CORP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 88,242 shares valued at US$8.7M — a reduction of -3,954 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 103.95K $10.07M New
Q4 2023 103.63K $11.41M Hold
Q1 2024 101.44K $11.53M Reduce
Q2 2024 99.75K $10.37M Reduce
Q3 2024 95.89K $10.93M Reduce
Q4 2024 103.70K $11.73M Add
Q1 2025 105.71K $14.02M Add
Q2 2025 108.21K $14.72M Add
Q3 2025 112.08K $15.01M Add
Q4 2025 114.75K $14.38M Add
Q1 2026 112.77K $11.58M Reduce
Q2 2026 92.20K $8.37M Reduce
Q3 2026 88.24K $8.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has TOTH FINANCIAL ADVISORY CORP held ABT?

TOTH FINANCIAL ADVISORY CORP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TOTH FINANCIAL ADVISORY CORP's current position in ABT?

As of Q3 2026, TOTH FINANCIAL ADVISORY CORP holds 88.24K shares of ABT (ABBOTT LABORATORIES), valued at $8.72M, representing 0.87% of its reported portfolio and ranking #39.

Has TOTH FINANCIAL ADVISORY CORP been buying or selling ABT?

In the latest 13F filing (Q3 2026), TOTH FINANCIAL ADVISORY CORP reduced its position in ABT. The position peaked in Q3 2025 at 112.08K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.